Icon

ZILBRYSQ - (16.6MG/0.416ML, 23MG/0.574ML, 32.4MG/0.81ML)

ZILUCOPLAN SODIUM None
16.6MG/0.416ML, 23MG/0.574ML, 32.4MG/0.81ML
Less Than $1000 mn
None None
None None
None None
ZILBRYSQ is a complement inhibitor indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are antiacetylcholine receptor (AChR) antibody positive.
Yes
ZILBRYSQ Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.